Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
JNJ Johnson & Johnson daily Stock Chart
JNJ [NYSE]
Johnson & Johnson
Healthcare | Drug Manufacturers - Major | USA
financial highlights | statements
IndexDJIA S&P500 P/E25.69 EPS (ttm)5.40 Insider Own0.07% Shs Outstand2.66B Perf Week1.35%
Market Cap369.21B Forward P/E15.17 EPS next Y9.14 Insider Trans-9.84% Shs Float2.65B Perf Month-0.81%
Income14.68B PEG3.96 EPS next Q2.43 Inst Own69.40% Short Float0.48% Perf Quarter2.47%
Sales81.59B P/S4.53 EPS this Y7.60% Inst Trans-0.23% Short Ratio2.06 Perf Half Y-4.95%
Book/sh22.16 P/B6.26 EPS next Y6.33% ROA9.60% Target Price148.12 Perf Year12.16%
Cash/sh5.76 P/C24.07 EPS next 5Y6.48% ROE23.80% 52W Range118.62 - 148.99 Perf YTD7.52%
Dividend3.80 P/FCF41.80 EPS past 5Y3.10% ROI17.00% 52W High-6.87% Beta0.67
Dividend %2.74% Quick Ratio1.10 Sales past 5Y2.70% Gross Margin66.90% 52W Low16.98% ATR2.02
Employees135100 Current Ratio1.40 Sales Q/Q0.10% Oper. Margin20.80% RSI (14)50.85 Volatility1.26% 1.28%
OptionableYes Debt/Eq0.50 EPS Q/Q-13.00% Profit Margin18.00% Rel Volume0.88 Prev Close138.12
ShortableYes LT Debt/Eq0.47 EarningsApr 16 BMO Payout65.60% Avg Volume6.20M Price138.76
Recom2.30 SMA20-0.51% SMA500.31% SMA2001.37% Volume5,456,839 Change0.46%
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Oct-18-17Reiterated Leerink Partners Outperform $150 → $165
Oct-16-17Reiterated Jefferies Buy $157 → $160
Oct-11-17Upgrade Jefferies Hold → Buy
Oct-09-17Upgrade Wells Fargo Market Perform → Outperform
Sep-25-17Initiated Citigroup Neutral $140
Sep-20-17Downgrade Goldman Neutral → Sell $125 → $130
Jul-21-17Downgrade BTIG Research Neutral → Sell $110
Jul-21-17Downgrade Alembic Global Advisors Neutral → Underweight
Jul-20-17Resumed Credit Suisse Outperform $148
Jul-05-17Reiterated Morgan Stanley Overweight $135 → $140
May-22-19 05:45PM  Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know Zacks
02:42PM  Congo wants more use of Merck vaccine rather than J&J newcomer - minister Reuters
07:34AM  The Daily Biotech Pulse: Tocagen Tumbles, OncoSec Offering, Novartis Asthma Combo Drug Study Benzinga
May-21-19 12:29PM  West Chester company to eliminate 76 jobs American City Business Journals
08:16AM  The Zacks Analyst Blog Highlights: Johnson & Johnson, Apple, Goldman Sachs, IBM and Netflix Zacks
May-20-19 03:45PM  ARWR: ARO-AAT Ph 2/3 Detailed, Could Serve as FDA Pivotal Study. Continued Broad-Based Pipeline Progress Zacks Small Cap Research
03:13PM  Top Analyst Reports for Johnson & Johnson, Apple & Goldman Sachs Zacks
12:31PM  Drugmakers lobbying spending at 10-year high as Washington targets soaring prices MarketWatch
09:15AM  This is Why Johnson & Johnson (JNJ) is a Great Dividend Stock Zacks
09:02AM  AbbVie's Brain Cancer Candidate Fails in Phase III Study Zacks
06:37AM  After J&J sale, Cambridge investor sets sights on $175M raise for new medtech VC firm American City Business Journals
May-19-19 04:18AM  Modis jobs deficit - J&Js largest India plant idle three years after completion Reuters
04:08AM  Modis jobs deficit: J&Js largest India plant idle 3 years after completion Reuters
May-18-19 03:18PM  Bulls And Bears Of The Week: Apple, Chevron, FedEx, Uber And More Benzinga
12:19PM  6 Things Johnson & Johnson Wants You to Know About Its Pharmaceuticals Motley Fool
May-17-19 05:58PM  Trade war trades: 6 stocks CNBC Videos
05:30PM  Why This Biotech Stock Looks Prime For A Johnson & Johnson Buyout Investor's Business Daily
05:03PM  Exclusive: FBI targets Johnson & Johnson, Siemens, GE, Philips in Brazil graft case - Sources Reuters
04:43PM  Exclusive: FBI targets Johnson & Johnson, Siemens, GE, Philips in Brazil graft case - sources Reuters
04:43PM  Exclusive: FBI targets Johnson & Johnson, Siemens, GE, Philips in Brazil graft case - sources Reuters
01:34PM  U.S. FDA labels J&J surgical staplers' recall as severest Reuters
12:32PM  U.S. FDA labels J&J surgical staplers' recall as severest Reuters
10:45AM  FDA issues recall of J&J unit Ethicon's surgical staplers Reuters
09:18AM  Your first trade for Friday, May 17 CNBC
08:52AM  Johnson & Johnson to Participate in Bernstein's 35th Annual Strategic Decisions Conference PR Newswire
08:35AM  Pharma Stock Roundup: FDA Okays Line Extensions of LLY, PFE, ABBV Cancer Drugs Zacks
May-16-19 04:28PM  Did Geron's Big Announcement Just Go Unnoticed? Motley Fool
12:33PM  Johnson & Johnson Is a Defensive Stock. Now Theres Hope for Growth. Barrons.com
10:20AM  Johnson & Johnson Analysts Laud Accelerating Pharma Business Benzinga
09:30AM  Why Is Johnson & Johnson (JNJ) Down 1.2% Since Last Earnings Report? Zacks
May-15-19 05:06PM  Johnson & Johnson Unveils 5-Year Growth Plan for Pharmaceutical Business TheStreet.com
10:54AM  Johnson & Johnson to submit applications for at least 10 new drugs by 2023 Reuters
08:54AM  J&J analyst day drives focus on drug business as talc baby powder comes under fire CNBC
08:32AM  Johnson & Johnson CEO Alex Gorsky on what's in the pipeline, growth drivers and talc lawsuit CNBC Videos
08:18AM  Johnson & Johnson details a new five year plan CNBC Videos
07:19AM  Johnson & Johnson to submit applications for at least 10 new drugs by 2023 Reuters
06:40AM  Johnson & Johnson Outlines Strategy to Deliver Above-Market Growth at 2019 Pharmaceutical Business Review PR Newswire
05:34AM  Bull of the Day: Penumbra (PEN) Zacks
05:20AM  8 Stocks That Can Prosper Amid the Trade War Investopedia
May-14-19 06:11PM  Lawsuit accuses Gilead of propping up cost of lifesaving HIV treatments by blocking generic competition CNBC
May-13-19 11:01AM  Minerva Neurosciences Sinks To Lowest Level In A Year On Cloudy Midstage Trial Results For Depression Drug Benzinga
May-12-19 01:38PM  Johnson & Johnson Still Has Multiple Growth Drivers to Power Its Stock TheStreet.com
May-09-19 03:13PM  Drug Prices Will Be Included In TV Ads Under New Trump Admin Rule Benzinga
11:18AM  Perrigo (PRGO) Beats on Q1 Earnings and Sales, Stock Up Zacks
07:46AM  These 3 revolutionary genomics companies are changing lives for patients and investors MarketWatch
05:43AM  Takeda sheds products, 485 jobs in deals worth $5.7B American City Business Journals
May-08-19 07:44PM  TV pitches for prescription drugs will have to include price Associated Press
03:26PM  Drug makers forced to reveal prices on television ads CNBC Videos
11:44AM  Theravance (TBPH) Q1 Loss Widens, Revenues Miss Estimates Zacks
10:10AM  U.S. government to require drugmakers to show prices in TV ads Reuters
08:54AM  White House requires Big Pharma to list drug prices on TV ads as soon as this summer CNBC
May-07-19 02:52PM  10 Great Stocks to Buy on Dips InvestorPlace
12:25PM  J&J agrees to pay about $1 billion to resolve hip implant lawsuits: Bloomberg Reuters
12:14PM  J&J Pays About $1 Billion to Resolve Pinnacle-Hip Suits Bloomberg
12:08PM  WHO advisers recommend changes in Ebola vaccine strategy Reuters
08:47AM  Why Investors Should Buy Johnson & Johnson Stock on Every Dip InvestorPlace
May-06-19 10:43AM  Here are the biggest stock-market losers after Trump threatens more tariffs MarketWatch
09:58AM  Geron's (GERN) Q1 Earnings Beat, Revenues Miss, Stock Up Zacks
06:37AM  Two Healthcare Stocks in the XLV Fund Stand Out InvestorPlace
05:30AM  Boeings 737 Max Defense Is a Textbook Mess Bloomberg
May-05-19 07:32AM  Where Will Johnson & Johnson Be in 10 Years? Motley Fool
May-03-19 03:17PM  Congo Ebola deaths surpass 1,000 as attacks on treatment centres go on Reuters
01:15PM  Lowest Unemployment Rate in 50 Years: What To Buy Zacks
08:57AM  Congo Ebola death toll nears 1,000, expected to spread -WHO Reuters
06:10AM  Pharma Stock Roundup: MRK, LLY, PFE Report Q1 Earnings, SNY, ABBV Drugs Get EU Nod Zacks
May-02-19 09:00PM  Pacira BioSciences Rocks in Q1 With Strong Momentum for Pain Drug Exparel Motley Fool
07:30PM  2 Dividend Stocks to Supplement Your Social Security Income Motley Fool
12:13PM  Vistagen Shares Fall Under $1 After Depression Drug Flunks Midstage Trial Benzinga
09:16AM  Glaxo (GSK) Beats on Q1 Earnings & Sales, Shingrix Impresses Zacks
09:15AM  Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio Zacks
06:00AM  Investors Pressure Firms on Opioid Crisis Morningstar
04:41AM  Insys founder convicted in opioid bribery case Financial Times
May-01-19 06:56PM  The Top Pharma Stocks for 2019 Investopedia
02:40PM  Jabil Inc. -- Moody's upgrades Jabil to Baa3; outlook stable Moody's
01:08PM  Jim Cramer: Why Investors Should Wait to Buy Johnson & Johnson TheStreet.com
12:02PM  How Much Did Johnson & Johnson's (NYSE:JNJ) CEO Pocket Last Year? Simply Wall St.
Apr-30-19 03:18PM  Trump, Democratic leaders to meet on drug prices soon -White House Reuters
01:00PM  Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates Benzinga
11:42AM  Romano's Macaroni Grill founder talks SA past and millennial future American City Business Journals
11:14AM  Family commits $1.25 million to Triad university scholarship American City Business Journals
10:54AM  10 Workhorse Health Care Stocks That Never Break a Sweat Kiplinger
09:48AM  Merck (MRK) Beats on Q1 Earnings & Sales as Keytruda Shines Zacks
09:33AM  Pfizer (PFE) Beats on Q1 Earnings & Sales, Raises EPS View Zacks
07:00AM  Companies add fertility benefits to attract job seekers American City Business Journals
06:45AM  3 Warren Buffett Stocks Worth Buying Now Motley Fool
06:00AM  Why This Could Be the Most Dangerous Time Ever to Invest in Healthcare Stocks Motley Fool
Apr-26-19 05:55PM  3 Dividend Aristocrats to Buy and Hold Forever Motley Fool
04:26PM  Gut Check: The Bacteria In Your Intestines Could Help Cure Cancer Investor's Business Daily
02:54PM  4 Health Care Stocks That Are Starting to Heat Up InvestorPlace
11:19AM  Legal Risk Weighs on Johnson & Johnson Stock InvestorPlace
07:26AM  Alkermes (ALKS) Reports Narrower-Than-Expected Loss in Q1 Zacks
Apr-25-19 04:21PM  5 Top Stock Trades for Friday Morning: Facebook, 3M, Tesla and Comcast InvestorPlace
03:08PM  Mr. Wonderful, Oz Pearlman and the Beardstown Ladies make their first round stock picks CNBC Videos
02:55PM  The Top 10 Biotechnology Companies (JNJ, ROG.VX) Investopedia
11:50AM  Can Keytruda Drive Merck's (MRK) Q1 Earnings and Sales? Zacks
11:15AM  AbbVie (ABBV) Beats on Q1 Earnings & Sales, Raises EPS View Zacks
10:45AM  Johnson & Johnson raises quarterly dividend by 5.6% to 95 cents a share MarketWatch
10:40AM  Johnson & Johnson Announces Dividend Increase of 5.6% PR Newswire
07:35AM  India alleges big multinationals did not pass on tax benefits: source Reuters
Apr-24-19 06:44PM  Johnson & Johnson to Host Pharmaceutical Business Review PR Newswire
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; sterilization and disinfection products to reduce surgical infection; diabetes care products; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. It has research and collaboration alliance with Morphic Therapeutic. The company was incorporated in 1887 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sneed Michael EEVP, Global Corp Aff & COOFeb 11Option Exercise0.007,275051,687Feb 12 09:14 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 11Option Exercise0.0016,968036,138Feb 12 09:14 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 11Option Exercise0.007,541021,809Feb 12 09:14 PM
Gorsky AlexChairman, CEOFeb 11Option Exercise0.0073,9470414,703Feb 12 09:14 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 11Option Exercise0.0022,6240122,430Feb 12 09:14 PM
Kapusta Ronald AController, CAOFeb 11Option Exercise0.002,839018,231Feb 12 09:15 PM
Wolk Joseph JExec VP, CFOFeb 11Option Exercise0.002,903014,405Feb 12 09:15 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 11Option Exercise0.0012,609093,947Feb 12 09:15 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 11Option Exercise0.006,722044,546Feb 12 09:15 PM
Ullmann Michael HExec VP, General CounselFeb 11Option Exercise0.0013,2730139,434Feb 12 09:15 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 11Option Exercise0.009,748078,388Feb 12 09:15 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 11Option Exercise0.0031,4280242,246Feb 12 09:15 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 08Option Exercise0.0012,5710215,138Feb 12 09:15 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 08Option Exercise0.008,529072,205Feb 12 09:15 PM
Ullmann Michael HExec VP, General CounselFeb 08Option Exercise0.005,3090128,294Feb 12 09:15 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 08Option Exercise0.005,882040,197Feb 12 09:15 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 08Option Exercise0.005,044083,371Feb 12 09:15 PM
Wolk Joseph JExec VP, CFOFeb 08Option Exercise0.002,540012,239Feb 12 09:15 PM
Kapusta Ronald AController, CAOFeb 08Option Exercise0.002,484016,125Feb 12 09:15 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 08Option Exercise0.009,0490102,604Feb 12 09:14 PM
Gorsky AlexChairman, CEOFeb 08Option Exercise0.0029,5790352,464Feb 12 09:14 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 08Option Exercise0.006,599016,092Feb 12 09:14 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 08Option Exercise0.006,787022,179Feb 12 09:14 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 08Option Exercise0.006,365046,239Feb 12 09:14 PM
PRINCE CHARLESDirectorDec 14Buy134.372,000268,73128,520Dec 17 08:37 AM
MULCAHY ANNE MDirectorDec 14Buy133.76748100,0506,537Dec 17 08:37 AM
PEREZ WILLIAM DDirectorDec 14Buy133.911,000133,9109,122Dec 17 08:37 AM
Kapusta Ronald AController, CAODec 13Sale147.313,643536,63813,641Dec 14 04:33 PM
Fasolo PeterExec VP, Chief HR OfficerDec 04Option Exercise96.7341,5634,020,237119,890Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 04Sale146.6841,5636,096,55278,327Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 03Option Exercise94.12125,13211,777,919203,459Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 03Sale146.32125,13218,308,68978,327Dec 06 05:27 PM
Sneed Michael EEVP, Global Corp Aff & COONov 23Option Exercise58.3330,9431,804,90570,817Nov 27 06:56 PM
Sneed Michael EEVP, Global Corp Aff & COONov 23Sale142.4630,9434,407,98539,874Nov 27 06:56 PM
Gorsky AlexChairman, CEONov 16Option Exercise62.39264,46516,500,026601,024Nov 16 07:44 PM
Gorsky AlexChairman, CEONov 16Sale145.96264,46538,600,968336,559Nov 16 07:44 PM
Kapusta Ronald AController, CAONov 08Sale145.158,4411,225,20017,284Nov 09 05:22 PM
Duato JoaquinVice Chair, Exec CommitteeNov 07Option Exercise62.9440,0002,517,526133,555Nov 09 05:20 PM
Duato JoaquinVice Chair, Exec CommitteeNov 07Sale144.3640,0005,774,48093,555Nov 09 05:20 PM
Kapusta Ronald AController, CAOSep 07Sale137.187,8991,083,60725,725Sep 11 03:53 PM
Sneed Michael EEVP, Global Corp Aff & COOAug 27Option Exercise58.3329,0001,691,57059,124Aug 28 04:03 PM
Sneed Michael EEVP, Global Corp Aff & COOAug 27Sale134.8029,0003,909,08430,124Aug 28 04:03 PM
open in yahoo | open in reuters | open in google